412 related articles for article (PubMed ID: 24764241)
21. Advances in Engineered Liver Models for Investigating Drug-Induced Liver Injury.
Lin C; Khetani SR
Biomed Res Int; 2016; 2016():1829148. PubMed ID: 27725933
[TBL] [Abstract][Full Text] [Related]
22. Kidney-on-a-Chip: A New Technology for Predicting Drug Efficacy, Interactions, and Drug-induced Nephrotoxicity.
Lee J; Kim S
Curr Drug Metab; 2018; 19(7):577-583. PubMed ID: 29521220
[TBL] [Abstract][Full Text] [Related]
23. Characterization of rat or human hepatocytes cultured in microphysiological systems (MPS) to identify hepatotoxicity.
Chang SY; Voellinger JL; Van Ness KP; Chapron B; Shaffer RM; Neumann T; White CC; Kavanagh TJ; Kelly EJ; Eaton DL
Toxicol In Vitro; 2017 Apr; 40():170-183. PubMed ID: 28089783
[TBL] [Abstract][Full Text] [Related]
24. Liver Microphysiological Systems for Predicting and Evaluating Drug Effects.
Ribeiro AJS; Yang X; Patel V; Madabushi R; Strauss DG
Clin Pharmacol Ther; 2019 Jul; 106(1):139-147. PubMed ID: 30993668
[TBL] [Abstract][Full Text] [Related]
25. TAMH: A Useful In Vitro Model for Assessing Hepatotoxic Mechanisms.
Davis M; Stamper BD
Biomed Res Int; 2016; 2016():4780872. PubMed ID: 28074186
[TBL] [Abstract][Full Text] [Related]
26. Transcriptional profiling suggests that Nevirapine and Ritonavir cause drug induced liver injury through distinct mechanisms in primary human hepatocytes.
Terelius Y; Figler RA; Marukian S; Collado MS; Lawson MJ; Mackey AJ; Manka D; Qualls CW; Blackman BR; Wamhoff BR; Dash A
Chem Biol Interact; 2016 Aug; 255():31-44. PubMed ID: 26626330
[TBL] [Abstract][Full Text] [Related]
27. Metabolic activation and drug-induced liver injury: in vitro approaches for the safety risk assessment of new drugs.
Gómez-Lechón MJ; Tolosa L; Donato MT
J Appl Toxicol; 2016 Jun; 36(6):752-68. PubMed ID: 26691983
[TBL] [Abstract][Full Text] [Related]
28. Oxidative stress mediated idiosyncratic drug toxicity.
Tafazoli S; Spehar DD; O'Brien PJ
Drug Metab Rev; 2005; 37(2):311-25. PubMed ID: 15931767
[TBL] [Abstract][Full Text] [Related]
29. [Microfluidic cell culture array chip for drug screening assays].
Zheng Y; Wu J; Shao J; Jin Q; Zhao J
Sheng Wu Gong Cheng Xue Bao; 2009 May; 25(5):779-85. PubMed ID: 19670650
[TBL] [Abstract][Full Text] [Related]
30. Inhibition of bile salt transport by drugs associated with liver injury in primary hepatocytes from human, monkey, dog, rat, and mouse.
Zhang J; He K; Cai L; Chen YC; Yang Y; Shi Q; Woolf TF; Ge W; Guo L; Borlak J; Tong W
Chem Biol Interact; 2016 Aug; 255():45-54. PubMed ID: 27000539
[TBL] [Abstract][Full Text] [Related]
31. Novel 3D Culture Systems for Studies of Human Liver Function and Assessments of the Hepatotoxicity of Drugs and Drug Candidates.
Lauschke VM; Hendriks DF; Bell CC; Andersson TB; Ingelman-Sundberg M
Chem Res Toxicol; 2016 Dec; 29(12):1936-1955. PubMed ID: 27661221
[TBL] [Abstract][Full Text] [Related]
32. Sensitivities of gel entrapped hepatocytes in hollow fibers to hepatotoxic drug.
Meng Q; Zhang G; Shen C; Qiu H
Toxicol Lett; 2006 Sep; 166(1):19-26. PubMed ID: 16814964
[TBL] [Abstract][Full Text] [Related]
33. In vitro transcriptomic prediction of hepatotoxicity for early drug discovery.
Cheng F; Theodorescu D; Schulman IG; Lee JK
J Theor Biol; 2011 Dec; 290():27-36. PubMed ID: 21884709
[TBL] [Abstract][Full Text] [Related]
34. A long-term three dimensional liver co-culture system for improved prediction of clinically relevant drug-induced hepatotoxicity.
Kostadinova R; Boess F; Applegate D; Suter L; Weiser T; Singer T; Naughton B; Roth A
Toxicol Appl Pharmacol; 2013 Apr; 268(1):1-16. PubMed ID: 23352505
[TBL] [Abstract][Full Text] [Related]
35. Sandwich-cultured hepatocytes: utility for in vitro exploration of hepatobiliary drug disposition and drug-induced hepatotoxicity.
De Bruyn T; Chatterjee S; Fattah S; Keemink J; Nicolaï J; Augustijns P; Annaert P
Expert Opin Drug Metab Toxicol; 2013 May; 9(5):589-616. PubMed ID: 23452081
[TBL] [Abstract][Full Text] [Related]
36. Human hepatocytes derived from pluripotent stem cells: a promising cell model for drug hepatotoxicity screening.
Gómez-Lechón MJ; Tolosa L
Arch Toxicol; 2016 Sep; 90(9):2049-2061. PubMed ID: 27325232
[TBL] [Abstract][Full Text] [Related]
37. Stem cell-derived models to improve mechanistic understanding and prediction of human drug-induced liver injury.
Goldring C; Antoine DJ; Bonner F; Crozier J; Denning C; Fontana RJ; Hanley NA; Hay DC; Ingelman-Sundberg M; Juhila S; Kitteringham N; Silva-Lima B; Norris A; Pridgeon C; Ross JA; Young RS; Tagle D; Tornesi B; van de Water B; Weaver RJ; Zhang F; Park BK
Hepatology; 2017 Feb; 65(2):710-721. PubMed ID: 27775817
[TBL] [Abstract][Full Text] [Related]
38. Towards a three-dimensional microfluidic liver platform for predicting drug efficacy and toxicity in humans.
Bhushan A; Senutovitch N; Bale SS; McCarty WJ; Hegde M; Jindal R; Golberg I; Berk Usta O; Yarmush ML; Vernetti L; Gough A; Bakan A; Shun TY; DeBiasio R; Lansing Taylor D
Stem Cell Res Ther; 2013; 4 Suppl 1(Suppl 1):S16. PubMed ID: 24565476
[TBL] [Abstract][Full Text] [Related]
39. Prediction of drug-induced immune-mediated hepatotoxicity using hepatocyte-like cells derived from human embryonic stem cells.
Kim DE; Jang MJ; Kim YR; Lee JY; Cho EB; Kim E; Kim Y; Kim MY; Jeong WI; Kim S; Han YM; Lee SH
Toxicology; 2017 Jul; 387():1-9. PubMed ID: 28645575
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
